Cormedix Will Make Dialysis Much Safer and Healthier
by Brian Wang from NextBigFuture.com on (#6BJEA)
Brian Wang, Nextbigfuture, interviewed Joseph Todicso, CEO of Cormedix. DefenCathTM is Cormedix formulation of taurolidine and heparin that will greatly reduce dialysis infections for those using catheter lock solutions. It is trying to greatly reduce the risk of catheter-related bloodstream infections (CRBSIs) from central venous catheters (CVCs). Cormedix is making solid progress for regulatory and ...